Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.
about
ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesisVascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma.The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.Placental growth factor deficiency is associated with impaired cerebral vascular development in mice.The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosisCelecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.PlGF: a multitasking cytokine with disease-restricted activity.Endoplasmic reticulum stress and angiogenesis: is there an interaction between them?The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).Placental growth factor in cancer.Targeting the tumor stroma in hepatocellular carcinoma.Pathophysiology of portal hypertension and its clinical links.Novel treatment options for portal hypertension.Portal myofibroblasts connect angiogenesis and fibrosis in liver.Angiogenesis and Fibrogenesis in Chronic Liver Diseases.Molecular pathophysiology of portal hypertension.Placental Growth Factor Contributes to Liver Inflammation, Angiogenesis, Fibrosis in Mice by Promoting Hepatic Macrophage Recruitment and ActivationEndoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models.Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase.RNA-sequencing reveals long-term effects of silver nanoparticles on human lung cells.Nuclear factor-κB mediates placental growth factor induced pro-labour mediators in human placenta.Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented ReviewPlatelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-β1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated SignalingVEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury
P2860
Q34354002-1E88B376-C8A6-49B9-9BF6-9AF0EAF3A0BAQ34902424-D309B188-D0D2-44CD-8C3D-8941E954A738Q35136411-ECCDCF32-5E57-4E62-864F-4596E11AE53BQ35582077-3EC3020F-5941-4FFB-9FD3-C747571197D4Q35890853-26586D53-9BAB-436F-A50C-A19CA2EE9C13Q35998229-5F8F405E-5266-4F82-8628-2AE7CE9927E2Q36310780-D6AE987D-2E21-4E18-A912-9F82FEAB71BAQ36521436-467E9C41-D3B3-4D9B-B958-0DC15FCE3B9BQ37131689-AA542974-49C0-467B-A823-6F5D5A6171B6Q37262768-37B2B84A-B585-478B-8F49-B5B03216C4F3Q37557535-88DB5768-5B3F-42E3-9525-AA607D0EBF85Q38036234-682996CB-9FA2-4B3F-9A2A-263C72B084E4Q38176096-E91DBEAD-E45E-41F6-833C-1B17A7FF71C1Q38185910-2B5E6410-EA5C-471F-B46C-073D903EDDF9Q38258289-D7F7E97C-C0B1-4EA4-A34D-4E975C4F36D9Q38366586-FD40131B-C4A2-4B77-849C-987F60D19271Q38371453-772FBC45-2FE2-46E4-9DDA-658E23B12BA5Q38680437-1BE85194-4419-4320-8AB6-F710A137BDE1Q38870907-04C299AF-EF08-4890-BC8E-3CA63AEF16ECQ39140170-C1F2DAAD-8AE5-4609-AB23-6190E77CFE5CQ39148718-0F346270-5781-4C62-9A1A-FD74E572C7A3Q40974310-65A4536D-EA09-4244-B368-492CCF4D9EE1Q41811106-309A67E2-FCD0-461D-ACF6-24889A9E7FB5Q42365769-CFC97FEB-6FD8-4E7F-AF09-46653D036E76Q49140588-54C75568-A184-4872-B3F4-A2B862F44AD4Q49751930-35849FFC-84A3-4B52-94D3-C0BF5C2F187FQ52716082-D9A5BAC5-5417-4137-9642-E9FEF78F9BC6Q54325060-DCC5B0A4-5EB1-48E7-A372-AA57801C6795Q57066901-BC706648-5A7B-44AC-B601-B7013CC36CE0Q58716653-DAC16457-32F7-4C76-BCB7-52ED61FACF39Q58806294-6A80E765-08EC-4402-83EC-FFE8EC3F29CF
P2860
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@en
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@nl
type
label
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@en
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@nl
prefLabel
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@en
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Inhibition of placental growth ...... ypertension in cirrhotic mice.
@en
P2093
Anja Geerts
Ben Schroyen
Bram Blomme
Christophe Casteleyn
Christophe Van Steenkiste
Femke Heindryckx
Hans Van Vlierberghe
Hendrik Reynaert
Isabelle Colle
Jean Marie Stassen
P2860
P304
P356
10.1002/HEP.24238
P407
P577
2011-05-01T00:00:00Z